A mild synthetic method for N-formyl-Met-Leu-Phe-OH (1) is described. After Fmoc solid phase peptide synthesis, on-bead formylation and HPLC purification, more than 30 mg of the fully 13 C/ 15 N-labelled tripeptide 1 could be isolated in a typical batch. This peptide can be easily crystallised and is therefore well suited as a standard sample for setting up solid-state NMR experiments.
Introduction
There appears to be a general lack of widely available and standardised samples for setting up new solid-state NMR experiments. Such a standard sample should show a small 13 C and 15 N linewidth and a short 1 H T 1 relaxation time. It should contain a number of molecular groups with different chemical shifts for setting up correlation spectra. The 13 C/ 15 N-labelled tripeptide N-formyl-Met-Leu-Phe-OH (f-MLF-OH) (1) has been shown in a number of solid-state NMR studies to fulfil these criteria. It has been used in great detail to examine spin dynamics in peptide and for distance measurements [1] [2] [3] [4] [5] [6] [7] [8] [9] . MLF is a chemotactic peptide which plays an important role in antibody research [10] .
Although this tripeptide was briefly commercially available in the past, only one synthesis of f-MLF-OH (1) by solid phase methods has been published so far [11] . Rigorous reaction conditions (EtOH, reflux, 24-65 h) were required to couple the first Boc-protected amino acid to the solid support (chloromethyl resin) and long reaction times (18 h) were necessary to attach further building blocks to the growing peptide chain. The formylation of the N-terminus with formic acid/acetic anhydride was carried out after cleavage from the resin with liquid hydrogen fluoride [11, 12] . No experimental procedures were given in all subsequent publications. In this work, we present for the first time in detail an improved practical synthesis for fully 13 C/ 15 N-labelled f-MLF-OH (1) based on the Fmocstrategy.
Results and Discussion

Peptide Synthesis
The synthesis of the MLF tripeptide started with the immobilisation of 13 C/ 15 N-labelled Fmoc-Phe-OH to the solid support (Wang resin 2). This esterification step, leading to 3 quantitatively, was performed by activating the COOH group with MSNT under mild reaction conditions (Scheme 1) [13] . Full conversion of the resin bound hydroxy groups could be demonstrated by a colourimetric test with Dabcyl-COOH [14] . After removal of Fmoc with piperidine, the 13 C/ 15 N-labelled monomers Fmoc-Leu-OH and Fmoc-Met-OH were successively coupled to the solid support with DIC/HOBt [15] . Quantitative conversion in each reaction was monitored by the Kaiser test [16, 17] . The resulting tripeptide 4 was formylated under mild conditions with 13 C-labelled ethyl formate to obtain 5 [18] . The main advantage of using ethyl formate is the possibility of re-isolation of the expensive 13 C-labelled reagent for further formylation reactions, due to the absence of activating agents. To the best of our knowledge, formylation reactions of N-termini with ethyl formate have never been reported before in solid phase peptide synthesis. Other methods of formylation were not tested, since they require elevated reaction temperatures or acidic conditions [19, 20] , which might cause some premature removal of the peptide from the resin. The final step was the cleavage of f-MLF-OH (1) from the solid support with TFA [21, 22] . To prevent by-product formation from electrophilic intermediates present in the cleavage process, EDT and TIS were added as scavengers [23, 24] .
Conclusion
Compared to the solution phase synthesis of peptides, the solid phase synthesis offers a simplified purification of the intermediates. With the improved synthetic protocol based on Fmoc building blocks, where all reaction steps were carried out at room temperature, we were able to obtain the per-13 C/ 15 Nlabelled formylated Met-Leu-Phe tripeptide as carboxylic acid in acceptable yields [32.8 mg (23%) after HPLC purification]. Due to the selected reagents, i.e. MSNT for the esterification, DIC/HOBt for the peptide coupling and ethyl formate for the formylation, shorter reaction time and quantitative conversion could be accomplished when compared to the previous protocol from 1976 [11] , where yields are not given. In contrast to the Boc-strategy, the Fmoc-method for solid phase peptide synthesis has the advantage of orthogonal conditions for the removal of N-protective groups and the cleavage from the Wang resin [25] . Unintentional release of the growing peptide chain thus could be excluded. In addition, the use of liquid hydrogen fluoride is no longer required.
Experimental
General: All reagents were obtained from commercial suppliers and were used without further purification. In case of a successful peptide extension, the Fmoc-protecting group was removed with piperidine (25% in DMF). Afterwards, the last coupling step was started by adding a solution of 13 Formylation of the N-terminus: For the following formylation, 13 C-labelled ethyl formate (2 mL) was aspirated and the syringe was shaken over night at room temperature. The quantitative conversion was proved by the Kaiser test, after washing the resin with CH 2 Cl 2 (5 ×). 
Supporting Information
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